AMRN Q2 2019 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$335M

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$101M+91.5% YoY

Gross Profit

$78M77.4% margin

Operating Income

-$3M-2.5% margin

Net Income

-$2M-1.8% margin

EPS (Diluted)

$-0.11

QoQ Revenue Growth

+37.5%

Cash Flow

Operating Cash Flow

$16M

Free Cash Flow

$15M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$390M

Total Liabilities

$241M

Stockholders' Equity

$149M

Cash & Equivalents

$222M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$101M	$53M	+91.5%
Gross Profit	$78M	$40M	+96.0%
Operating Income	-$3M	-$32M	+92.2%
Net Income	-$2M	-$34M	+94.7%

Revenue Segments

Product

$100M100%

License

$426,0000%